Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $22.7100 (-4.34%) ($22.6000 - $23.8500) on Thu. Sep. 26, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.73% (three month average) | RSI | 41 | Latest Price | $22.7100(-4.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2% a day on average for past five trading days. | Weekly Trend | EDIT declines -3.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(63%) ARKG(59%) IWO(58%) XBI(58%) ARKK(55%) | Factors Impacting EDIT price | EDIT will decline at least -1.365% in a week (0% probabilities). VIXM(-32%) VXX(-17%) UUP(-6%) TLT(-3%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.365% (StdDev 2.73%) | Hourly BBV | 0 () | Intraday Trend | -4.3% | | | |
|
1 - 5 Day Possible Target | $16.48(-27.43%) | Resistance Level | $24.76 | 5 Day Moving Average | $23.95(-5.18%) | 10 Day Moving Average | $24.67(-7.94%) | 20 Day Moving Average | $24.76(-8.28%) | To recent high | -15.3% | To recent low | 1.8% | Market Cap | $1.41b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |